You need to have an account to use this functionality.
please sign in or Register

Adjuvant Capital

active

Adjuvant is an investment firm providing finance to the most promising life science technologies for high-burden public health challenges.

Headquarters

United States of America,New York

Founded in

2018

Company Size

1–10 Employees

investor type

Venture Capital

investment stage

Early Growth Stage.Late Growth Stage

Company Size

1–10 Employees

Sectors of focus

Health & Pharmaceuticals

geographical focus

Global

Team

FUNDING ROUNDS

logo
54gene Healthcare & Pharma
Amount $15,000,000
Date Apr 14, 2020
Funding Round
Series A
investors
Adjuvant Capital
logo
54Gene Healthcare & Pharma
Amount $25,000,000
Date Sep 16, 2021
Funding Round
Series B
investors
Cathay AfricInvest Innovation Fund, Adjuvant Capital, KdT Ventures, Plexo Capital, Endeavor Capital, Ingressive Capital

RECENT ARTICLES ABOUT Adjuvant Capital

Digest Africa

CONTACT

info@digestafrica.com

Digest Africa Technologies Ltd
Ntinda Complex,
Block B, Level 3 Ntinda,
Kampala, Uganda

© Digest Africa Technologies Ltd 2023.
All Rights Reserved.